Currently out of the existing stock ratings of Joseph Munda, 14 are a BUY (77.78%), 4 are a HOLD (22.22%).

Joseph Munda

Work Performance Price Targets & Ratings Chart

Analyst Joseph Munda works at FIRST ANALYSIS with a stock forecast success ratio of 90% fulfilled within 539.6 days on average.

Joseph Munda’s has documented 40 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on NEO, NeoGenomics at 28-Feb-2020.

Wall Street Analyst Joseph Munda

Analyst best performing recommendations are on ANIK (ANIKA THERAPEUTICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/24/2018. The price target of $18 was fulfilled within 7 days with a profit of $3.59 (24.91%) receiving and performance score of 35.59.

Average potential price target upside

ANIK Anika Therapeutics LMAT LeMaitre Vascular NEO NeoGenomics ILMN Illumina SMED Sharps Compliance Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

37

$11.6 (45.67%)

28

10 days ago

10/12 (83.33%)

$11.74 (46.48%)

110

Buy

32

$6.6 (25.98%)

61

9 months 10 days ago

1/3 (33.33%)

$11.99 (59.92%)

73

Hold

35

1 years 7 months 5 days ago

0/2 (0%)

$8.78 (33.49%)

Hold

46

$23.44 (103.90%)

46

2 years 6 months 1 days ago

0/2 (0%)

$5.44 (13.41%)

Buy

65

$39.6 (155.91%)

54

4 years 4 months 9 days ago

5/6 (83.33%)

$15.2 (30.52%)

21

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Joseph Munda?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?